FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37173597> ?p ?o ?g. }

• Q37173597 description "article científic" @default.
• Q37173597 description "article scientifique" @default.
• Q37173597 description "articolo scientifico" @default.
• Q37173597 description "artigo científico" @default.
• Q37173597 description "artículu científicu espublizáu en 2015" @default.
• Q37173597 description "bilimsel makale" @default.
• Q37173597 description "scientific article published on 02 July 2015" @default.
• Q37173597 description "vedecký článok" @default.
• Q37173597 description "vetenskaplig artikel" @default.
• Q37173597 description "videnskabelig artikel" @default.
• Q37173597 description "vědecký článek" @default.
• Q37173597 description "wetenschappelijk artikel" @default.
• Q37173597 description "wissenschaftlicher Artikel" @default.
• Q37173597 description "наукова стаття, опублікована в липні 2015" @default.
• Q37173597 description "научни чланак" @default.
• Q37173597 description "مقالة علمية نشرت في 02 يوليو 2015" @default.
• Q37173597 description "২ জুলাই ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q37173597 name "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 name "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 name "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 type Item @default.
• Q37173597 label "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 label "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 label "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 prefLabel "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 prefLabel "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 prefLabel "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 P1433 Q37173597-308DF162-A03E-4327-B1D2-18C3E7A3D1BA @default.
• Q37173597 P1476 Q37173597-39FFE74A-F744-4C0D-BE52-5BF147410B34 @default.
• Q37173597 P2093 Q37173597-44A04DD1-07C8-4739-9929-AFBB17ECCBA3 @default.
• Q37173597 P2093 Q37173597-66B97FEF-FDDE-4485-8205-41F89C731AEA @default.
• Q37173597 P2093 Q37173597-842206EB-5A6E-45F8-AD98-20EA6D1BDD7F @default.
• Q37173597 P2093 Q37173597-8DFFD0D5-04A1-4B6F-A74D-EB3AD5B4D36D @default.
• Q37173597 P2093 Q37173597-98E17516-7F4F-4ED6-9A4C-FA601CFE9C7A @default.
• Q37173597 P2093 Q37173597-AD9DD661-E892-43C6-BA2B-323506CFF83E @default.
• Q37173597 P2093 Q37173597-AE097FCB-1FC8-4E1D-A701-EBD2DD290EBA @default.
• Q37173597 P2860 Q37173597-05526B85-ABBC-4CF6-8053-9AE7A1216B5C @default.
• Q37173597 P2860 Q37173597-0BCC8ED6-0F12-4EED-936E-9672554D0F47 @default.
• Q37173597 P2860 Q37173597-194FA40A-07C1-42C8-8C8A-51BBE79D0C9D @default.
• Q37173597 P2860 Q37173597-1C1CA969-4BF6-4675-A606-1EED387DA02D @default.
• Q37173597 P2860 Q37173597-2314EB0D-3CE1-49CD-9DB2-D61AB244DFEC @default.
• Q37173597 P2860 Q37173597-231A2898-E875-4459-A66C-E7487EB31FBB @default.
• Q37173597 P2860 Q37173597-30D41144-FECD-45B1-87F9-1643FBB84540 @default.
• Q37173597 P2860 Q37173597-3102C883-2196-4D9C-8DD5-E2A28CA5FA3A @default.
• Q37173597 P2860 Q37173597-341EA3A3-599D-493A-A468-FC1305B058F8 @default.
• Q37173597 P2860 Q37173597-349EAEFD-F0B3-4876-861B-35868AC4ABE8 @default.
• Q37173597 P2860 Q37173597-377D0AD0-4737-4613-A5B3-9749E46D3E54 @default.
• Q37173597 P2860 Q37173597-46D530B2-0C96-4F89-990B-D307176152A7 @default.
• Q37173597 P2860 Q37173597-4D36177C-3D47-48A4-AC11-15ECD26DECA9 @default.
• Q37173597 P2860 Q37173597-5094EA75-3EE1-47EE-9040-DA48E5292BE0 @default.
• Q37173597 P2860 Q37173597-5EE12008-A3CC-4C05-B78B-FA65CBD356EF @default.
• Q37173597 P2860 Q37173597-62C30394-788D-4208-9CA0-E0B8D61791E5 @default.
• Q37173597 P2860 Q37173597-6543FBAC-6462-4369-A0B6-8255956198E8 @default.
• Q37173597 P2860 Q37173597-690F68D3-66E1-4CF8-80B4-78318BA7FFC5 @default.
• Q37173597 P2860 Q37173597-6E337D92-CF26-4AE8-B9BB-AD708FED4124 @default.
• Q37173597 P2860 Q37173597-6EB75758-F6B3-4DC2-97C9-3502D8E955B9 @default.
• Q37173597 P2860 Q37173597-7307A8F4-7568-4BB8-B921-6BCC0386436C @default.
• Q37173597 P2860 Q37173597-75B21F71-0450-48B9-AB4F-ADCCD93EB71A @default.
• Q37173597 P2860 Q37173597-77263E13-95E1-41DC-9D3A-EC21687C93F7 @default.
• Q37173597 P2860 Q37173597-7B115297-BF1B-4F54-BA1E-DDC09FF16A03 @default.
• Q37173597 P2860 Q37173597-7C730944-0677-4525-86CA-E7EC610E593C @default.
• Q37173597 P2860 Q37173597-83D21D43-6B4F-4EC4-B029-1E986CBFE3E4 @default.
• Q37173597 P2860 Q37173597-8A8656E2-95B3-44F3-A095-A7F2B0E879E0 @default.
• Q37173597 P2860 Q37173597-92E36194-662C-42E8-9BFB-0B9CBF0613E3 @default.
• Q37173597 P2860 Q37173597-9867D8A3-4424-4F90-8902-61C10F14946F @default.
• Q37173597 P2860 Q37173597-9AB93700-641D-4B0C-ACD3-0680AEDFB216 @default.
• Q37173597 P2860 Q37173597-9E888C38-EFA6-44EC-AE59-9968D3F5A1FF @default.
• Q37173597 P2860 Q37173597-A07E1B86-57FA-4E12-B64C-090290D76A84 @default.
• Q37173597 P2860 Q37173597-A3EA998D-7CAD-4F0D-BD6F-F35E33E21CEF @default.
• Q37173597 P2860 Q37173597-AA9D9DDD-94B1-43E8-9B98-F05513FF0AF4 @default.
• Q37173597 P2860 Q37173597-B3841A09-CFA4-4802-9109-136143E535BF @default.
• Q37173597 P2860 Q37173597-BC7B2926-0322-4162-9C9F-F2EBED1A1A20 @default.
• Q37173597 P2860 Q37173597-BFC1354D-8AA0-40E5-B430-E4811868C7A6 @default.
• Q37173597 P2860 Q37173597-C32C6455-1D89-4E77-A8C3-F831C2BFAB74 @default.
• Q37173597 P2860 Q37173597-C9675D9F-F971-4A73-9DDB-987D2C442AED @default.
• Q37173597 P2860 Q37173597-CC8EE13F-D4F5-4EF7-A8FB-CE6598F7397A @default.
• Q37173597 P2860 Q37173597-D16F26F4-4BCE-46E7-AEDC-EE52C0F90780 @default.
• Q37173597 P2860 Q37173597-D280379E-070B-40EF-87D2-4164942DB67D @default.
• Q37173597 P2860 Q37173597-D2E183E3-E5F1-4FDB-9F5A-05835A54C114 @default.
• Q37173597 P2860 Q37173597-D305E9DB-AAE4-40E9-9895-87611A3C0F74 @default.
• Q37173597 P2860 Q37173597-E12DE7E5-14DC-4C6B-BBAE-1BFE3CAFD04B @default.
• Q37173597 P2860 Q37173597-E3C1C860-9751-42F1-96DD-7D3FE2772F9F @default.
• Q37173597 P2860 Q37173597-EBF15246-3229-4B71-A3CF-BD8066B41A5A @default.
• Q37173597 P2860 Q37173597-F29DC27E-1546-4299-9C97-C0FAA1509F64 @default.
• Q37173597 P2860 Q37173597-F73B77D0-7224-45EC-B71F-A682E0715A64 @default.
• Q37173597 P2860 Q37173597-F91A97C7-619B-4BBD-9B8A-AE61C17EAE36 @default.
• Q37173597 P304 Q37173597-DFB223BD-EFD4-413C-906E-18A61F104F66 @default.
• Q37173597 P31 Q37173597-A581799E-B92B-4514-997B-DEED8480380E @default.
• Q37173597 P356 Q37173597-FFF50B81-5B6E-44CD-B119-D3A7C7CC6E33 @default.
• Q37173597 P433 Q37173597-EC11609E-47BE-45BF-BB7B-42785C182B9C @default.
• Q37173597 P478 Q37173597-C196724D-AD31-48C4-BD20-BE42B890C009 @default.
• Q37173597 P577 Q37173597-31A69581-B956-4253-9286-1D691DBA7F6C @default.
• Q37173597 P698 Q37173597-1EBB8477-2F8A-4A26-AB59-1B3B2FD2B676 @default.
• Q37173597 P921 Q37173597-BAD23206-CB94-4E87-B5C0-940B34851AD2 @default.
• Q37173597 P932 Q37173597-666FA46B-F833-431A-8554-AE6C42A753DC @default.
• Q37173597 P356 2326-6066.CIR-15-0044 @default.
• Q37173597 P698 26138335 @default.
• Q37173597 P1433 Q26841983 @default.
• Q37173597 P1476 "CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer" @default.
• Q37173597 P2093 "Dallas B Flies" @default.

• next